← Back to patent-cliff list
Octreotide chloride
Tier C — Watch / tradeOctreotide chloride
Camurus Ab
Originator
2025
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：SSTR
Brand：Oczyesa
Indications (approved)：Acromegaly
Regional status
US
Filed / under review
2024-10-22
EU
Approved
2025-06-30
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Octreotide chloride?
Approved indications include: Acromegaly.
When does the Octreotide chloride patent expire?
No public expiry year is available for Octreotide chloride yet; this page updates once verified.
How do I get a quote for Octreotide chloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01